Clinical trial Recruiting at 1 site Interventional Ages 21 to 60

Bone level changes after equicrestal versus subcrestal dental implant placement in augmented posterior mandible

Official title: Radiographic Evaluation of Crestal Bone Changes Following Equi-crestal Versus Subcrestal Implant Placement in Mandibular Posterior Augmented Ridge. A Randomized Controlled Clinical Trial.

Run by Misr International University · NCT06760442 · Data updated 2026-11-12

This trial will try whether placing implants slightly below the bone crest (subcrestal) versus level with the crest (equicrestal) leads to less crestal bone loss in adults who had prior mandibular ridge augmentation.

Quick facts

Study typeInterventional
Ages21 Years to 60 Years
SexAll
Enrollment28 (estimated)
SponsorMisr International University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedJuly 1, 2027
Study endsDecember 1, 2027
Registry record updatedJuly 16, 2026
Trial IDNCT06760442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21 or older with previously augmented edentulous posterior mandibular sites (vertical height >10 mm and ridge width ≥7 mm), good oral hygiene, favorable occlusion, and willingness to attend an 18-month follow-up.

Probably not a fit

Patients who smoke, have systemic conditions or habits that impair healing, inadequate bone volume or active local infection, remaining roots at the site, or who are pregnant are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, parallel randomized controlled trial enrolling 36 participants who previously received horizontal bone augmentation in posterior mandible sites and now need delayed implant placement. Participants are randomized to receive either subcrestal or equicrestal implant placement and will be followed for 18 months. Crestal bone changes will be measured on periapical radiographs at implant placement and at 3, 6, 12, and 18 months, while keratinized tissue width and soft tissue thickness will be measured clinically with a periodontal probe. Buccal bone changes will also be evaluated during the follow-up period.

Why it matters

Potential benefit: If successful, the approach could reduce crestal bone loss around implants in augmented posterior mandibles, improving long-term implant stability and esthetics.

How similar studies have gone: Previous comparisons of subcrestal versus equicrestal placement have shown mixed results, with some reports of modest reductions in crestal bone loss for subcrestal placement but no clear consensus.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients older than 21 years.
* Patients having augmented (by 50/50 particulate xenograft and autogenous bone) edentulous posterior site with vertical bone height of \> 10 mm in the mandible with a width of ridge ≥ 7 mm

  * Adequate Inter-arch space for implant placement
  * Favorable occlusion (no traumatic occlusion).
* Good oral hygiene.•Accepts 18 months follow-up period (cooperative patient)
* The patient provides informed consent.

Exclusion Criteria:

* Patients with inadequate bone volume and/ or quality
* Patients with remaining roots or with signs of acute infection related to the area of interest.
* Patients having systemic conditions that interfere with normal wound healing
* Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits .
* Smoker patients.
* Pregnant women.

Where it's running

  • Misr International University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.